280 related articles for article (PubMed ID: 30353759)
1. The assessment of different risk classification systems for gastrointestinal stromal tumors (GISTs): the analytic results from the SEER database.
Zhao B; Zhang J; Mei D; Zhang J; Luo R; Xu H; Huang B
Scand J Gastroenterol; 2018; 53(10-11):1319-1327. PubMed ID: 30353759
[TBL] [Abstract][Full Text] [Related]
2. Clinical utility of the new American Joint Committee on Cancer staging system for gastrointestinal stromal tumors: current overall survival after primary tumor resection.
Rutkowski P; Wozniak A; Dębiec-Rychter M; Kąkol M; Dziewirski W; Zdzienicki M; Ptaszynski K; Jurkowska M; Limon J; Siedlecki JA
Cancer; 2011 Nov; 117(21):4916-24. PubMed ID: 21456019
[TBL] [Abstract][Full Text] [Related]
3. Which is the optimal risk stratification system for surgically treated localized primary GIST? Comparison of three contemporary prognostic criteria in 171 tumors and a proposal for a modified Armed Forces Institute of Pathology risk criteria.
Goh BK; Chow PK; Yap WM; Kesavan SM; Song IC; Paul PG; Ooi BS; Chung YF; Wong WK
Ann Surg Oncol; 2008 Aug; 15(8):2153-63. PubMed ID: 18546045
[TBL] [Abstract][Full Text] [Related]
4. Performance of risk stratification systems for gastrointestinal stromal tumors: A multicenter study.
Chen T; Ye LY; Feng XY; Qiu HB; Zhang P; Luo YX; Yuan LY; Chen XH; Hu YF; Liu H; Li Y; Tao KX; Yu J; Li GX
World J Gastroenterol; 2019 Mar; 25(10):1238-1247. PubMed ID: 30886506
[TBL] [Abstract][Full Text] [Related]
5. A new nomogram for recurrence-free survival prediction of gastrointestinal stromal tumors: Comparison with current risk classification methods.
Chen T; Xu L; Ye L; Qiu H; Hu Y; Liu H; Zhou Z; Li G; Yu J
Eur J Surg Oncol; 2019 Jun; 45(6):1109-1114. PubMed ID: 30594406
[TBL] [Abstract][Full Text] [Related]
6. Comparison of three prognostic models for predicting cancer-specific survival among patients with gastrointestinal stromal tumors.
Oweira H; Schmidt J; Mehrabi A; Kulaksiz H; Schneider P; Schöb O; Giryes A; Abdel-Rahman O
Future Oncol; 2018 Feb; 14(4):379-389. PubMed ID: 29318911
[TBL] [Abstract][Full Text] [Related]
7. Two staging systems for gastrointestinal stromal tumors in the stomach: which is better?
Park CH; Kim GH; Lee BE; Song GA; Park DY; Choi KU; Kim DH; Jeon TY
BMC Gastroenterol; 2017 Dec; 17(1):141. PubMed ID: 29207963
[TBL] [Abstract][Full Text] [Related]
8. Outcomes After Surgical Resection Differ by Primary Tumor Location for Metastatic Gastrointestinal Stromal Tumors (GISTs): a Propensity Score Matching Population Study.
Gaitanidis A; Alevizakos M; Tsaroucha A; Pitiakoudis M
J Gastrointest Cancer; 2019 Dec; 50(4):750-758. PubMed ID: 30033508
[TBL] [Abstract][Full Text] [Related]
9. Risk stratification systems for surgically treated localized primary Gastrointestinal Stromal Tumors (GIST). Review of literature and comparison of the three prognostic criteria: MSKCC Nomogramm, NIH-Fletcher and AFIP-Miettinen.
Belfiori G; Sartelli M; Cardinali L; Tranà C; Bracci R; Gesuita R; Marmorale C
Ann Ital Chir; 2015; 86(3):219-27. PubMed ID: 26098671
[TBL] [Abstract][Full Text] [Related]
10. Analysis of risk factors of gastrointestinal stromal tumors in different age groups based on SEER database.
Ge XY; Lei LW; Ge F; Jiang X
Scand J Gastroenterol; 2019 Apr; 54(4):480-484. PubMed ID: 31017491
[No Abstract] [Full Text] [Related]
11. [Comparison of modified NIH and AFIP risk-stratification criteria for gastrointestinal stromal tumors: A multicenter retrospective study].
Chen T; Qiou H; Feng X; Zhang P; Ye L; Hu Y; Liu H; Yu J; Tao K; Li Y; Zhou Z; Li G
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1020-1024. PubMed ID: 28900993
[TBL] [Abstract][Full Text] [Related]
12. Comparative clinical features and short-term outcomes of gastric and small intestinal gastrointestinal stromal tumours: a retrospective study.
Yang Z; Wang F; Liu S; Guan W
Sci Rep; 2019 Jul; 9(1):10033. PubMed ID: 31296939
[TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal stromal tumors (GISTs) at uncommon locations: a large population based analysis.
Kukar M; Kapil A; Papenfuss W; Groman A; Grobmyer SR; Hochwald SN
J Surg Oncol; 2015 May; 111(6):696-701. PubMed ID: 25560251
[TBL] [Abstract][Full Text] [Related]
14. Clinical and prognostic significance of Raf kinase inhibitory protein expression in gastrointestinal stromal tumors.
Wang Y; Chen JJ; Wang XF; Wang Q
World J Gastroenterol; 2018 Jun; 24(23):2508-2517. PubMed ID: 29930472
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of gastric gastrointestinal stromal tumors in Shandong Province: a midterm report of multicenter GISSG1201 study].
Hou Q; Luo W; Li L; Dai Y; Jiang L; Wang A; Chu X; Li Y; Yang D; Lu C; Yao L; Cui G; Lin H; Chen G; Cui Q; Zhang H; Lun Z; Xia L; Su Y; Han G; Hui X; Wei Z; Sun Z; Guo H; Zhou Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1025-1030. PubMed ID: 28900994
[TBL] [Abstract][Full Text] [Related]
16. Characteristics and prognosis of jejunoileal gastrointestinal stromal tumours (GISTs) in the era of imatinib: a comparative study with gastric GISTs.
Fernández JA; Ferreras D; Ruiz-Manzanera JJ; Olivares V; Ferri B; Frutos MD; Martínez J
Clin Transl Oncol; 2021 Jul; 23(7):1368-1376. PubMed ID: 33515420
[TBL] [Abstract][Full Text] [Related]
17. Predictors of lymph node metastasis in patients with gastrointestinal stromal tumors (GISTs).
Gaitanidis A; El Lakis M; Alevizakos M; Tsaroucha A; Pitiakoudis M
Langenbecks Arch Surg; 2018 Aug; 403(5):599-606. PubMed ID: 29855800
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological Outcomes and Prognosis of Elderly Patients (≥ 65 Years) with Gastric Gastrointestinal Stromal Tumors (GISTs) Undergoing Curative-Intent Resection: a Multicenter Data Review.
Yang Z; Feng X; Zhang P; Chen T; Qiu H; Zhou Y; Du C; Yin X; Pan F; Zheng G; Liu X; Huang C; Zhou Z; Li G; Tao K; Li Y
J Gastrointest Surg; 2019 May; 23(5):904-913. PubMed ID: 30324400
[TBL] [Abstract][Full Text] [Related]
19. A modification of NIH consensus criteria to better distinguish the highly lethal subset of primary localized gastrointestinal stromal tumors: a subdivision of the original high-risk group on the basis of outcome.
Huang HY; Li CF; Huang WW; Hu TH; Lin CN; Uen YH; Hsiung CY; Lu D
Surgery; 2007 Jun; 141(6):748-56. PubMed ID: 17560251
[TBL] [Abstract][Full Text] [Related]
20. Blood neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios are independent prognostic factors for surgically resected gastrointestinal stromal tumors.
Goh BK; Chok AY; Allen JC; Quek R; Teo MC; Chow PK; Chung AY; Ong HS; Wong WK
Surgery; 2016 Apr; 159(4):1146-56. PubMed ID: 26688506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
